In 2028, the value of multiple sclerosis (MS) treatment market in the Middle East region was expected to reach around 4.5 billion U.S. dollars. In 2017 the value of multiple sclerosis (MS) treatment market in the region was 2.3 billion U.S. dollars.
Value of multiple sclerosis (MS) treatment in the Middle East from 2017 to 2022 with forecasts to 2028 (in million U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic U.S. pancreatic cancer treatment market size from 2014 to 2024, by affected region
- Basic Statistic Distribution of top funders for HIV/AIDS research and development 2022
- Basic Statistic Nobel Prize Laureates in medicine by nationality up to 2023
- Premium Statistic Market share of major varicella vaccine manufacturers in China 2020
- Basic Statistic Turnover of medicines sold in retail pharmacies in France 2005-2018
- Premium Statistic Medicare's costliest drugs 2015
- Premium Statistic Household expenditure on health care in Italy 2012-2022
- Basic Statistic Rate of inflation health services and goods in Belgium 2018-2023
- Premium Statistic Vaccinated one-year-old children in Colombia 2016-2021, by vaccine
- Premium Statistic Colorado medical and recreational marijuana sales 2014-2022
About the region
10
- Premium Statistic Share of fatalities in Kuwait by major cause 2019
- Premium Statistic Share of fatalities in the UAE 2019, by major cause
- Premium Statistic Share of fatalities in Saudi Arabia 2019, by major cause
- Premium Statistic Share of fatalities in Bahrain by major cause 2019
- Premium Statistic Share of fatalities in Qatar by major cause 2019
- Premium Statistic Tuberculosis incidence rate in the UAE 2006-2022
- Premium Statistic Tuberculosis incidence rate in Qatar 2006-2022
- Premium Statistic Tuberculosis incidence rate in Kuwait 2006-2022
- Premium Statistic Tuberculosis incidence rate in Oman 2006-2022
- Premium Statistic Tuberculosis incidence rate in Saudi Arabia 2006-2022
Other regions
10
- Premium Statistic Ischemic heart disease - deaths in selected countries 2020
- Premium Statistic Number of people with type 2 diabetes in Denmark 2008-2022
- Premium Statistic Number of meningococcal disease cases in Italy 2011-2020
- Basic Statistic Coronavirus (COVID-19) cases in Kenya 2020-2022
- Basic Statistic Mean payment per elderly Medicare beneficiary with and without Alzheimer's U.S. 2023
- Basic Statistic Diabetes prevalence adults in selected countries 2021
- Premium Statistic Number of new cancer cases Philippines 2020, by type
- Premium Statistic Incidence of tuberculosis India 2015-2019
- Premium Statistic Cumulative number of COVID-19 deaths in Botswana from March 2020 to August 2021
- Premium Statistic Number of persons with bleeding disorders in Greece 2020
Related statistics
10
- Premium Statistic Tuberculosis incidence rate in Bahrain 2006-2022
- Premium Statistic Tuberculosis incidence rate in the GCC by country 2020
- Basic Statistic Cumulative number of COVID-19 cases in Iraq 2022
- Basic Statistic Cumulative number of COVID-19 cases in Lebanon 2022
- Basic Statistic Cumulative number of COVID-19 cases in Qatar 2022
- Basic Statistic Coronavirus cases, recoveries, and deaths in Iran as of July 20, 2020
- Basic Statistic Daily increase of COVID-19 cases in Iraq 2020
- Basic Statistic Daily increase of COVID-19 cases in Lebanon 2020
- Basic Statistic Daily increase of COVID-19 cases in Qatar 2020
- Basic Statistic Daily increase of COVID-19 cases in Bahrain 2020
Further related statistics
10
- New cases of shigellosis in the U.S. 1950-2019
- Rate of new cases of tuberculosis in the U.S. 1960-2019
- New cases of Lyme disease in the U.S. 1991-2019
- Size of U.S. hospices by number of admissions 2012-2014
- Preventive care and screenings taken by adults aged 65 or older 2010
- New cases of mumps in the U.S. 1970-2019
- Location of death among hospice patients in the U.S. 2018
- Top 10 most expensive conditions treated in the U.S. - hospitals stays 2017
- Net earnings of UnitedHealth Group 2007-2023
- Overweight prevalence in England 2000-2021, by gender
Further Content: You might find this interesting as well
Statistics
- New cases of shigellosis in the U.S. 1950-2019
- Rate of new cases of tuberculosis in the U.S. 1960-2019
- New cases of Lyme disease in the U.S. 1991-2019
- Size of U.S. hospices by number of admissions 2012-2014
- Preventive care and screenings taken by adults aged 65 or older 2010
- New cases of mumps in the U.S. 1970-2019
- Location of death among hospice patients in the U.S. 2018
- Top 10 most expensive conditions treated in the U.S. - hospitals stays 2017
- Net earnings of UnitedHealth Group 2007-2023
- Overweight prevalence in England 2000-2021, by gender
Reports and Insights. (April 6, 2023). Value of multiple sclerosis (MS) treatment in the Middle East from 2017 to 2022 with forecasts to 2028 (in million U.S. dollars) [Graph]. In Statista. Retrieved May 14, 2024, from https://www.statista.com/statistics/1380520/mena-value-of-multiple-sclerosis-ms-treatment/
Reports and Insights. "Value of multiple sclerosis (MS) treatment in the Middle East from 2017 to 2022 with forecasts to 2028 (in million U.S. dollars)." Chart. April 6, 2023. Statista. Accessed May 14, 2024. https://www.statista.com/statistics/1380520/mena-value-of-multiple-sclerosis-ms-treatment/
Reports and Insights. (2023). Value of multiple sclerosis (MS) treatment in the Middle East from 2017 to 2022 with forecasts to 2028 (in million U.S. dollars). Statista. Statista Inc.. Accessed: May 14, 2024. https://www.statista.com/statistics/1380520/mena-value-of-multiple-sclerosis-ms-treatment/
Reports and Insights. "Value of Multiple Sclerosis (Ms) Treatment in The Middle East from 2017 to 2022 with Forecasts to 2028 (in Million U.S. Dollars)." Statista, Statista Inc., 6 Apr 2023, https://www.statista.com/statistics/1380520/mena-value-of-multiple-sclerosis-ms-treatment/
Reports and Insights, Value of multiple sclerosis (MS) treatment in the Middle East from 2017 to 2022 with forecasts to 2028 (in million U.S. dollars) Statista, https://www.statista.com/statistics/1380520/mena-value-of-multiple-sclerosis-ms-treatment/ (last visited May 14, 2024)
Value of multiple sclerosis (MS) treatment in the Middle East from 2017 to 2022 with forecasts to 2028 (in million U.S. dollars) [Graph], Reports and Insights, April 6, 2023. [Online]. Available: https://www.statista.com/statistics/1380520/mena-value-of-multiple-sclerosis-ms-treatment/